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Abstract 
 
Overweight and obesity are chronic diseases, which are increasingly affecting children and 
adolescents, and if not treated immediately then fat children from today will become patients 
from tomorrow.  
The objective of this study was to investigate whether dietary fat restriction normalizes body 
weight, impaired glucose tolerance and endothelium-dependent contractions induced by high 
dietary fat intake in young rodents. C57BL/6J mice, 4 weeks of age, were divided into 
Control group, which was fed with standard rodent chow (12% of fat); High-Fat group, which 
was fed for 30 weeks with the high-fat (HF) diet (41% fat) and Fat Restriction group, which 
was fed for 15 weeks with the HF diet (41% of fat), followed by standard chow (12% of fat) 
for 15 weeks. Body weight was monitored and glucose tolerance test was performed. Vascular 
responses to acetylcholine were investigated in aortic and carotid artery rings ex vivo in the 
absence or presence of nitric oxide and prostanoids.  
Body weight was increased in the High-Fat group and was normalized in the Fat Restriction 
group to similar levels as in the Control group. Impaired glucose tolerance detected in High-
Fat group was normalized in the Fat Restriction group. In the High-Fat group, endothelium-
dependent contractions were increased in aorta and carotid arteries, and these contractions 
were attenuated in the Fat Restriction group to the same level as in the Control group. 
Moreover, the extent and sensitivity of these contractions varied between aorta and carotid 
arteries in the presence or absence of nitric oxide. 
In conclusion, intake of high amounts of fat leads to weight gain, glucose intolerance and 
enhanced endothelium-dependent contractile responses in aorta and carotid artery of young 
mice. All these effects were normalized after dietary fat restriction. These findings thus 
suggest that long term reduction in intake of dietary fat improves the metabolic and vascular 
function in young mice. 
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1.   Introduction  
1.1. Obesity 
The growing prevalence of obesity has become a serious health problem, in both developed 
and developing countries, regardless of age, sex, ethnicity or socio-economic background.1 
Obesity is a chronic disease and predisposes to metabolic syndrome, which is a composition 
of metabolic risk factors that consists of elevated glucose associated with insulin resistance, 
serum elevations of triglycerides, low levels of high-density lipoprotein, elevated blood 
pressure, and a prothrombotic and proinflammatory state.2, 3 A parameter to detect overweight 
and obesity is the body mass index (BMI).                               
 A BMI between 20-24.9 indicates normal weight, between 25.0-29.9 is overweight and 30 
and above BMI indicates obesity.4 In general, for each unit of BMI increment, the risk of 
coronary diseases increases by 8%.5 However, BMI should not be used as the only criteria for 
evaluating obesity. There is now substantial evidence suggesting that evaluating the regional 
distribution of fat is far more important, than simple weight recordings. To assess abdominal 
fat distribution, the waist-to-hip circumference ratio (WHR) is an important prediction 
criteria.6 The deposition of fat in the upper region of the body, or central obesity, is a better 
predictor of morbidity than excess fat in the lower body.6 Therefore, recent studies emphasize 
on the accurate estimations on the distribution of the body fat for better prognosis of 
pathological changes.6  
Like in the rest of Europe, the number of individuals being overweight or obese is increasing 
in Switzerland.7, 8 A recent national study shows that the prevalence of overweight and 
obesity is 29.4% and 7.7%, respectively in the Swiss population older than 15 years. This 
represents a total of 37.1%, which is more than one third of the adult population in 
Switzerland.9 
 
BMI =
Weight (kg)
Height (m2)
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1.1.1. Childhood Obesity 
Alarmingly, the prevalence of overweight and obesity is also increasing in children and 
adolescents. It is estimated that one in 10 children are overweight and under the age of 5 years 
over 22 million children are overweight worldwide.1  In Europe, about 30% of children are 
overweight and approximately one quarter of these are obese.10, 11  In Switzerland, the 
prevalence of overweight and obese boys and girls were 17%  and 19%, respectively, in 
2002.10 France and Switzerland have data for over 40 years and both countries suggest, that 
since early 1960s the prevalence of overweight and obesity has increased.10 The situation in 
Switzerland is even more dramatical: the incidence of overweight has almost quadrupled from 
5 to 22%.12 It is estimated that the number of overweight children will increase by 17%, and 
of obese children by over 19% from 2006 to 2010 in the European Union.12 
The prevalence of overweight and obesity among children is more and more a worrisome 
clinical problem.13 Girls with overweight upon entering adulthood have higher chances of 
developing other complications. When they become pregnant, their risk of developing glucose 
intolerance and gestional diabetes increases markedly. Consequently, they then produce 
heavier babies who are themselves prone to become obese in early childhood.14 A recent 
review estimated that over 20,000 obese European children presently suffer from type 2 
diabetes, most of it is unrecognized and hence untreated, and over 400,000 have impaired 
glucose tolerance.12 At least 1 million obese European children are likely to manifest 
indicators of cardiovascular disease and metabolic syndrome, and almost 1.5 million are 
likely to suffer from early stages of liver disorder.12 In children, the relation between systolic 
blood pressure and elevated visceral fat accumulation, serum insulin, leptin and family history 
of hypertension was shown by Nishina et al. in 2003.15 In this study, 109 Japanese obese 
children aged 6-15 years with a family history of hypertension and 83 Japanese obese children 
with no family history for high blood pressure were included. The results of the study suggest 
that the association between systolic blood pressure with visceral fat accumulation, 
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hyperleptinemia and hyperinsulinemia was independent  of a family history of hypertension.15 
Similar results were also reported in studies with adult obesity.15 In obese children, a lower 
distentibility of the common carotid artery and a significant lower arterial compliance than in 
the healthy controls has been reported. These findings suggest that severe obesity is 
associated with increased endothelium dysfunction and arterial wall stiffness.16 In another 
study, overweight children presented an impaired endothelial function and an increased 
carotid-intima media thickness.17 The elevation of BMI correlated with the severity of 
endothelial dysfunction.17 Thus, childhood obesity may damage or impair vascular function 
resulting in accelerated development of vascular-related diseases. 
 
1.1.2. Diseases Associated with Obesity 
1.1.2.1. Atherosclerosis 
Atherosclerosis is a chronic inflammatory systemic disease of the vasculature which is the 
main cause for most cardiovascular diseases such as coronary artery disease, congestive heart 
failure, peripheral artery disease, stroke, ischemic bowel disease and diabetic nephropathy.18-
20. In Westernized societies, the reason for 50% of all deaths is atherosclerosis.21 Stroke 
accounts for the majority of invalidity. In developing countries the incidence of 
atherosclerosis is rapidly rising as well.22 According to the Pathobiological Determinants of 
Atherosclerosis in Youth (PDAY) study, obesity was associated with coronary atherosclerosis 
in young men but not in young women.23 Epidemiological studies have revealed several 
important environmental and genetic risk factors associated with atherosclerosis. Risk factors 
include elevated LDL and low HDL cholesterol levels, hypertension, hyperglycemia and 
diabetes, as well as aging, male gender and estrogen deficiency. Other risk factors are 
smoking, physical inactivity, genetic variability and chronic inflammatory processes.18, 21, 24-26  
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The development of atherosclerosis, a pathological process, begins already during fetal life.27 
The fetal aorta can already show early lesion of the atherosclerotic plaque, the so-called fatty 
streak.27, 28 Maternal hypercholesterolemia may aggravate this formation.27 Elevated plasma 
lipids may play an essential role for onset and progression of early fetal atherosclerosis.28 
Juvenile obesity results in unfavorable changes in plasma lipids,29 and mediates the 
progression of atherosclerotic lesion formation.30 Thus, the above studies suggests that 
atherosclerosis is not only an age-related disease but can also develop in early life. 
 
1.1.2.2. Coronary Artery Disease  
In obese people, when all risk factors for coronary artery disease coexist, the condition leads 
to the development of cardiovascular disease (CVD) causing increased morbidity and 
mortality.3 Using a cohort of 2005 men and 2521 women, the Framingham Study showed that 
the 28-year age-adjusted rate (per 100) of coronary heart disease (CHD) in men was 26.3 for a 
mean BMI of 21.6 kg/m2 and 42.2 for a mean BMI of 31. Whereas in women the score was 
19.5 for a BMI of 20.4 and 28.8 for a BMI of 32.3, respectively.31 The Framingham risk score 
(FRS) allows early risk identification for coronary artery disease (CAD).32 For the calculation 
of FRS, gender, age, total cholesterol to HDL cholesterol ratio, systolic blood pressure, left 
ventricular hypertrophy (LVH), type II diabetes and cigarette smoking were used.32  The 
relationship between carotid artery intima-media thickness (IMT) and FRS parameters is 
important in evaluating the development of coronary atherosclerosis.32 In black and white 
population, a significant, positive linear relationship between FRS and IMT of the different 
carotid segments (common, bulb and internal part) were observed.32 The importance to 
control multiple risk factors and to prevent early onset of CAD is underscored by these 
results.32 Another multivariate analysis, the Gothenberg Study, showed that the waist-hip ratio 
(WHR) was the strongest predictor of myocardial infarction in 1462 women during a follow 
up of 12 years.3, 33 An observation over 20 years by the Honolulu Heart Program 
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demonstrated that a mean subscapular skinfold thickness of 27.2 mm increased the risk of 
CHD in Japanese American.34 All these epidemiological studies indicate that overweight and 
obesity increases the risk for developing CAD, not only in men but also in women. 
 
1.1.2.3. Diabetes mellitus Type II 
Obesity is strongly associated with type II diabetes mellitus.35 The manifestation of obesity 
associated diabetes has become increasingly common and the incidence of diabetes is 
predicted to double in the next 30 years.35, 36 Epidemiological studies suggest that most 
children or adolescents with T2DM (Type II Diabetes mellitus) are obese.37 Increased 
accumulation of visceral fat may lead to elevated secretion of free fatty acids and 
inflammatory cytokines, and a concomitant reduction in anti-inflammatory cytokines38-40. 
This may lead to the development of insulin resistance. The metabolic disorders that 
characterize diabetes, such as hyperglycemia, increased free fatty acids, and insulin resistance 
cause vascular dysfunction and mediate cardiovascular complications, including 
microvascular disease like retinopathy, neuropathy and nephropathy.41, 42 
 
1.1.2.4. Other Obesity-Associated Diseases 
Obesity increases the risk of death from all forms of cancers. Obesity elevates the levels of 
hormones which may influence cancer development. Excess estrogen is linked with cancers of 
the reproductive system and the adipose tissue is a major site of estrogen synthesis in 
women.43  
Other important diseases associated with obesity include abdominal hernias, varicose veins, 
gout, gall bladder disease, respiratory diseases such as obstructive sleep apnea and obesity 
hypoventilation syndrome, kidney diseases and liver malfunction.43  
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1.1.3. Economic Aspects of Obesity 
The cost of obesity-related disorders are estimated in the range of 2-8% of total health care 
costs, clearly one of the largest expenditure in health care budgets.10 In addition to the direct 
costs of obesity as a disease, certain indirect costs are also associated with obesity such as 
reduced output due to sickness absence and premature death of workers (NAO, National 
Accounting Office, 2001).10 In 2002, the UK National Accounting Office (NAO) estimated 
that total (direct and indirect) cost of treating obesity and its consequences amounted to £3.3-
3.7 billion (~ CHF 5.54-6.21 billion).10 Recently Branca et al., reported that according to 
WHO the costs of treating obesity-related disorders (such as cardiovascular disease, type II 
diabetes and certain types of cancer) were 6% of total health care costs in countries of Europe. 
Similar indirect costs were estimated due to lost productivity.10 In Switzerland in 2001, the 
total costs, direct and indirect, were CHF 2648 million. Of these CHF 1374 million were 
assigned to overweight and CHF 1273 million towards obesity.9 The costs for overweight and 
obesity was proportionally equivalent (51.1 vs. 48.9%).9 Only a small number of studies 
assess the various potential economic consequences of obesity or high BMI at the individual 
or household level, the so-called micro-level costs.10 It is suggested that women, who are 
overweight, are likely to earn less than women with normal body weight.44 Obesity is in this 
way  associated with negative effects, like social stigma and decreased labour productivity.10 
 
1.2. The Vasculature and Basic Structure 
1.2.1. Endothelial and Smooth Muscle Cells 
The vasculature is composed of several layers of tunica. The outermost is known as tunica 
adventitia, which is composed of external elastic membrane and connective tissue. The 
middle layer is the tunica media, which is primarily composed of vascular smooth muscle 
cells and the elastic fibers. The innermost lining of the blood vessel facing the lumen is the 
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tunica intima, which is composed of the endothelial cells and connective tissues. The 
endothelial and vascular smooth muscle cells (VSMCs) play a central role in the regulation of 
cardiovascular tone by providing either contraction or relaxation. Moreover theses cells are 
potentially involved in the maintenance of cardiovascular health and in regulating the 
progression of disease.45 Furchgott and Zawadzki described in 1980 that the endothelium is a 
major regulator of vascular homeostasis.46,47 The endothelium, built by endothelial cells, is a 
thin layer of flat cells that lines the interior surface of the entire circulatory system, from the 
heart to the smallest capillary.47 It is located  between the VSMCs and circulating blood as the 
inner lining of blood vessels.47 In a human body with about 70 kg, the endothelium weighs 
about 1 to 1.5 kg and covers the inner layer of  about 700 m2.47 The endothelium releases 
humoral factors that control relaxation and contraction, thrombogenesis, fibrinolysis and 
platelet activation.48 In this way the endothelium plays an important role for the maintenance 
of blood flow and anti-thrombotic function.48 Endothelial dysfunction leads to cardiovascular 
disorders like hypertension, atherosclerosis, heart failure and finally to vascular occlusion and 
end-organ damage.47  
The vascular smooth muscle cells surround the endothelial cells.49  Vascular smooth muscle 
cells are involved in the development of vascular bed, in vascular related diseases and during 
repair after mechanical trauma or inflammation. 50-52 The main function of vascular smooth 
muscle cells (VSMCs) is contraction.53 These cells show phenotypic variability and flexibility 
and express VSMCs-specific marker genes like smooth muscle (SM) -actin, SM-myosin 
heavy chain (MHC), caldesmon, telokin,  SM22-, h1-calponin and  smoothelin.50 Under 
normal quiescent condition VSMCs show a very small rate of proliferation and synthetic 
activity.50 VSMCs show a high rate of proliferation and migration in early embryonic 
development.51, 52 In the embryogenesis, the expression of several gene markers and the 
production of different proteins such as extracellular matrix protein (ECM) is highly 
induced.54, 55 In healthy mature organisms, VSMCs are in differentiated state and regulate 
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vascular tone, which is their primary function.53 Vascular diseases or injury can disturb this 
differentiated state. In this situation a phenotypic modulation or switching of the VSMCs 
takes places. This process (de-differentiation) is characterized by increased proliferation, 
migration and decreased expression of VSMC-specific marker genes.50  
VSMCs are able to perform specialized function, dependent on their anatomical localisation 
for example arteries versus veins, large versus small arteries, vascular versus 
gastrointestinal.51, 52 In the different types of vascular beds, VSMCs mediate different 
functions like calcium regulation in phasic versus tonic blood vessels and regulating the 
myogenic tone between large versus small arteries.56 Important for this different functionality 
is the diverse embryological origin of the VSMCs.57 The main population of the VSMCs are 
derived from the local mesoderm. VSMCs of coronary arteries have their origin from the 
proepicardial organ and major blood vessels in the head and neck have their origin in the 
neural crest, that may be important in the morphogenesis of brachial-arch-derived vessels.58 
Circulating stem cells derived from bone marrow can give rise to VSMCs or VSMC-like cells 
in situation of inflammation, severe vascular injury or tissue/ organ transplantation/ 
rejection.58 
By a good teamwork between the endothelium cells and  the VSMCs,  the functional integrity 
of the vasculature is ensured.48 
 
1.3. Vascular Function 
1.3.1. Vasoactive Factors 
The endothelium plays an important role in the control and maintenance of the blood flow, 
and for different metabolic processes taking place in the vascular wall.47 The endothelium has 
the ability to synthesize and release various substances and also controls the tone of smooth 
muscle cells, platelet aggregation, leukocyte migration, inflammatory processes and responses 
to circulating substances.59-61 In obesity, the integrity of the endothelium is disturbed and the 
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balance between relaxation and contraction is altered towards contraction.62 The most 
important vasodilators are acetylcholine60, prostacyclin  (prostaglandin I2)63, bradykinin64, 65 
and the endothelium-derived hyperpolarization factor (EDHF).65 The most important 
vasoconstrictors include the 21-amino acid peptide endothelin-1 (ET-1),66 thromboxane A267, 
prostanoids, prostaglandin H2  and components of the renin-angiotensin system such as 
angiotensin II. 68, 69  
 
1.3.2. Endothelium-Dependent Reactivity 
1.3.2.1. Relaxation 
The endothelium-derived vasodilators are prostacyclin (prostaglandin I2),63 nitric oxide 
(NO),70 the endothelium-derived hyperpolarization factor (EDHF).65 Prostacyclin is primarly 
produced in the vascular wall by endothelial cells.48 Prostacyclin increases cyclic 3`,5`-
adenosine monophosphate (cAMP)–concentrations, which activate ATP-sensitive potassium 
channels in smooth muscle cells and platelets.71  
Several isoforms of nitric oxide synthase (NOS) exist in endothelial cells, vascular smooth 
muscle cells, macrophages, platelets, nerves and the brain.72 These isoforms are endothelial 
nitric oxide synthase (eNOS/NOS3), inducible NOS (iNOS/NOS2) and neural NOS 
(nNOS/NOS1).72  
Acetylcholine activates endothelium-dependent NO synthesis, which is important for 
vasodilation.73 Endothelium-dependent relaxations due to NO involve formation of cyclic 
3`,5`-guanosine monophosphate (cGMP) via the action of soluble enzyme guanylyl cyclase.74 
L-NAME (NG-nitro-L-arginine methylester ), an irreversible inhibitor of eNOS, competes 
with L-arginine at the catalytic site and pharmacologically inhibits NO production.72 By 
releasing nitric oxide (NO) the endothelium causes a relaxant response in neighbouring 
vascular smooth muscle cells.75 It is remarkable to note, that the vasculature is always in state 
of vasodilation by a constant basal release of NO.47 Bradykinin is also involved in the 
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formation of vasodilating factors such as NO, prostanoids and EDHF.  The endothelium-
dependent hyperpolarizing factor (EDHF) is another important vasodilator. The molecules 
mediating EDHF are still unknown. Molecules that probably may be involved are potassium 
ions, hydrogen peroxide and epoxyeicosatreinoic acids.76, 77  
 
1.3.2.2. Contraction 
As already noted the endothelium also mediates contraction. The most important 
vasoconstrictors (endothelium-derived contracting factors)  are the 21-amino acid peptide 
endothelin-1 (ET-1),66 vasoconstrictor prostanoids such as thromboxane A267 and 
prostaglandin H2  and components of the renin-angiotensin system such as angiotensin II. 68 69 
Release of ET-1 is stimulated by thrombin, transforming growth factor-beta, interleukin-1, 
epinephrine, angiotensin II, arginine vasopressin, calcium ionophore and phorbol ester.78, 79 
To date, two different endothelin receptors are known: ETA- and ETB-receptors.47 Both 
receptors are coupled with a G-protein and linked to phospholipase C and protein kinase C.47 
At low ET-1 concentrations, ET-B- receptors are involved in dilation via  the formation of NO 
and prostacyclin while at high ET-1 concentrations ETA-receptors mediate contraction in 
smooth muscle cells.47 Thus, ET-1 can cause vasodilation and contraction depending on the 
concentration.78  
Another system, which is also regulated by the endothelium is the renin-angiotensin system. 
The endothelial cell membrane expresses the angiotensin-converting enzyme (ACE), which 
converts angiotensin I to angiotensin II. Angiotensin II activates endothelial angiotensin 
receptors, which stimulates the production of ET-1 and other mediators, leading to 
vasoconstriction.80  
Endothelium-derived contracting factors (EDCFs) are generated via the cyclooxygenase 
pathway. Arachidonic acid, acetylcholine, histamine and serotonin can evoke endothelium-
dependent contractions that are mediated by thromboxane A2 or prostaglandin H2.69 
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Thromboxane A2 and prostaglandin H2 activate thromboxane receptors in vascular smooth 
muscle cells and platelets.69 In both cell types, thromboxane A2 and prostaglandin H2 
neutralize the vasodilating effect of NO and prostacyclin.69 The cyclooxygenase pathway 
mediates contraction by producing superoxide anions, which rapidly inactivates NO to form 
the potent cytotoxic oxidant peroxynitrite, leading to vasoconstriction.69 There are two 
isoforms of cyclooxygenase: COX1 and COX2. A recent study in 2005 showed that 
endothelium-dependent contraction was absent in the aorta of COX1-/- knockout mice and 
present in that of COX2-/- knockout mice. These findings showed that only COX1 is the 
isoform of cyclooxygenase responsible for the production of  EDCF in mice.81 
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1.4. Aim of the study 
1.4.1. Hypothesis 
Obesity is a disease, which has become a worldwide health care problem. The prevalence of 
overweight and obesity is fast rising in adults and even in children. Restriction of dietary fat 
or switching from a high-fat to a low-fat diet lowers body weight. Based on this, the 
hypothesis of the present dissertation was that dietary fat restriction also improves 
endothelium-mediated vasoreactivity in different vascular beds in a recognized mouse model 
of obesity, the C57BL/6J mouse, fed with a high-fat diet. 
 
Main topics of interest were: 
 Whether dietary fat restriction restores weight gain and blood glucose levels in young 
animals. 
 Whether dietary fat restriction restores endothelium-dependent reactivity. 
 Whether vascular function differed between carotid artery and aorta. 
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2. Materials and Methods 
2.1. Experimental Animals 
Healthy male mice (C57BL/6J, Charles River, Sulzfeld Germany), 4 weeks of age underwent 
different dietary regimes for 30 weeks. The animals were housed at the animal facility of the 
“Biologisches Zentrallabor” of the University Hospital of Zurich. The animals were exposed 
on a 12:12-h light- dark cycle, and had free access tap water ad libitum. The room 
temperature was maintained at 22°C. Housing facilities and experimental protocols were 
approved by the local authorities for animal research (Kommission für Tierversuche des 
Kantons Zürich) and conform to the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No.85-23, revised 1996). 
 
2.2. Groups and Feeding Protocols 
Mice were randomly assigned to one of the following diets (n = 10-12 mice / group): Control 
group was fed with standard rodent chow (12.3% of total kcal from fat, Kliba Nafag 3430, 
Kaiseraugst, Switzerland) for 30 weeks; High-Fat group was fed with a high-fat diet (41% of 
total kcal from fat, Research Diets D 12079B, New Brunswick, NJ) for 30 weeks and  the Fat  
Restriction group  was fed with a high-fat diet (41% ot total kcal from fat) for 15 weeks, 
followed by 15 weeks feeding with standard rodent chow (12.3% fat). The macronutrient 
composition of the diets is listed in Table 1. The major source of the lipid fraction of the 
high-fat diet was composed of anhydrous milk fat, containing approximately 0.3% 
cholesterol. 
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Table 1 Major macronutrient constituents of diets given in percent of kcal 
Diet Control High-Fat 
Protein 22.4 17 
Carbohydrate 65.4 43 
Fat 12.3 41 
 
2.3. Glucose Tolerance Test 
In the week of the experiment, mice were fasted overnight for 14 h and body weight was 
measured. Venous blood was obtained from the tail vein (0 min) for baseline glucose 
measurements. Mice were subsequently injected (i.p.) with 2mg/g body weight D-glucose and 
blood was collected at 5, 10, 15, 30, 45, 60, 90 and 120 min. Blood glucose was determined 
with an Accu Chek Advantage glucose meter (Roche Diagnostics, Switzerland).  
 
2.4. Tissue Harvesting 
At the end of the feeding protocol, mice were anesthetized with xylazine (100 mg/kg body 
weight (BW); ketamine (23 mg/kg BW) and acepromazine (3.0 mg/kg BW), all 
intraperitoneal. When pain reflexes (in response to strong pain triggers on the toes) were 
absent, abdomen and chest were opened by laparotomy and medial sternotomy. Then the mice 
were subsequently exsanguinated via cardiac puncture. Blood vessels were identified and 
carefully excised. The thoracic aorta and carotid artery were isolated and placed in cold (4°C) 
Krebs Ringer bicarbonate solution of pH 7.4. The composition (in mmol/l) of Krebs buffer is 
as follows: NaCl 118.6, KCl 4.7; CaCl2 2.5; MgSO4 1.2 ; NaHCO3 25.1; KH2PO4 1.2; EDTA 
Na2Ca, 0.026; glucose 10.1). Under a microscope (Olympus SZX9, Volketswil, Switzerland) 
adherent connective, fat and muscle tissue was removed carefully from the arteries with 
microsurgical instruments. Special care was taken not to damage the endothelium or the 
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integrity of the smooth muscle cells during this procedure. Vessels were cut into 3.0 mm rings 
for thoracic aorta and 2.0-2.5 mm rings for carotid artery. 
 
2.5. Vascular Function Experiments 
2.5.1. Organ Chambers 
Vascular rings were mounted onto two tungsten wires (100 µm diameter) under the 
microscope. The aortic and carotid artery rings were transferred into water-jacketed 
prewarmed organ baths containing gassed (95% O2, 5% CO2) Krebs solutions at 37 °C with 
pH 7.4. Chamber volume was 10 ml. The rings were connected to a force transducers (Hugo 
Sachs Elektronic, Mach-Hugstetten, Germany), that allowed recording of isometric tension 
via an anchor. Before stretching the vessels, an equilibration time of 30 minutes was provided. 
To obtain an optimal level of passive tension, vessels were stretched step by step. Optimal 
stretching weights for aorta and carotid rings were 2.5g and 1.75g, respectively. These 
optimal weights were standardized based on earlier experiments in the laboratory. After 
another equilibration period of 20 minutes, the integrity of the vascular smooth muscle cell 
layer was verified by repeated exposure to potassium chloride (KCl, 100 mmol/L) until a 
stable response were achieved. The recordings were transferred to an X/Y-plotter (Rikadenki 
Elektronics, Tokyo, Japan) and printed. 
 
2.5.2. Experimental Protocols 
2.5.2.1. Acetylcholine 
To measure responses to acetylcholine (Ach), vessels were either left untreated, or incubated 
with the non-selective cyclooxygenase inhibitor meclofenamate (Meclo, 1 µmol/L) or the 
NO- synthase inhibitor NG-nitro-L-arginine methylester (L-NAME, 300 µmol/L). After 30 
minutes of incubation, vessels were precontracted to 50% KCl using cumulative 
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concentrations of phenylephrine (PE; 0.1-100 nmol/L). Endothelium-dependent responses to 
Ach were then examined by adding Ach (0.1 nmol/L-300 µmol/L) in a concentration-
dependent manner as shown in Fig. 1. 
 
 
 
 
 
 
 
 
 
 
Fig.  1: Representation of  a  typical  contraction  and  relaxation  curve  of  a  carotid  artery.  X 
correlates  to  5  minutes,  Y  correlates  to  0.25g.  Z  indicates  the  direction  of  the  protocol, 
starting with phenylephrine 0.1 nmol/L. * indicates endothelium‐dependent contractions to 
acetylcholine. 
 
2.6. Drugs 
Acetopromazine (Fatro, Ozzano Emilia, Italy), xylazine (Bayer, Zurich, Switzerland) and 
ketamine (Chassot AG, Bern Switzerland) were used for anesthesia. Acetylcholine 
hydrochloride, phenylephrine hydrochloride and meclofenamate were obtained from Sigma-
Aldrich (Buchs, Switzerland), and L-NAME was obtained from ALEXIS Biochemicals 
(Lausen, Switzerland). Drugs were dissolved in purified water (Millipore®, Volketswil 
Switzerland) and diluted with fresh cold Krebs solution to attain the concentration needed. 
Concentrations are expressed as final molar concentration in the organ chambers. 
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2.7. Calculations and Statistical Analysis 
The printed charts were manually digitized. The peak of the vascular response to the second 
exposure of potassium chloride (KCl, 100 mmol/L) was taken as reference value for 
contractions. Relaxations were expressed as percentage of precontraction in response to PE. 
For statistical analysis Microsoft Excel® for Windows® version 2003 and Statview® for 
Windows® version 5.0.1 were used. A P value smaller than 0.05 was considered significant 
and “n” is the number of animals used for the experiments. Two- tailed paired or unpaired 
Student`s t-test, ANOVA for repeated measurements followed by Bonferroni`s corrections 
were used when appropriate for the dataset. Values were represented in bar-graphs, line-
graphs or tables. To emphasize the difference between relaxation and contraction, percentage 
for relaxations were shown as negative values, whereas percentages for contractions were 
displayed as positive values. 
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3. Results 
3.1. Normalization of Weight Gain after Dietary Fat Restriction  
The changes in body weight were monitored throughout the experimental feeding period of 30 
weeks. In Table 1, the gain in weight in the Control, High-Fat and Fat Restriction groups are 
listed. The gain in weight was calculated by subtracting the initial weight at 4 weeks of age, 
measured before starting the diet, from the final weight at 34 weeks of age. Feeding of high-
fat diet for 30 weeks increased mouse body weight versus the Control group. Interestingly, 
animals subjected to fat restricted diet resulted in weight-loss and at the end of feeding 
protocol the weights were similar to control mice. 
 
Weight Gain 
Group Control  High-Fat  Fat Restriction 
Weight gain (g) 15.1± 0.7 19.6 ± 0.6* 15.1 ± 1.6† 
 
Table 1. Weight gain of mice in grams in Control, High‐Fat and Fat Restriction Groups after 30 weeks 
of  feeding  (n= 5‐13/  group).  *P<0.05  vs. Control;  †P<0.05  vs. High‐Fat. Values  represent means  ± 
standard error. 
 
 
3.2. Effect of High-Fat Diet and Dietary Fat Restriction on Glucose 
Levels 
 
Basal glucose levels (at 0 min) in starved animals were similar across all groups (Control: 
5.43±0.5 mmol/l; High-Fat: 6.15±0.2 mmol/L; Fat Restriction: 6.47±0.4 mmol/L). At 90 min 
after intraperitoneal injection of D-glucose (2mg/g of body weight), the blood glucose levels 
in all groups were higher compared to the 0 min (Fig. 2). The glucose level in High-Fat group 
at 90 min increased markedly in comparison to the Control group (High-Fat: 14.96 ±1.6 
mmol/L vs. Control: 8.31± 0.44 mmol/L; P< 0.05; Fig. 2). In the Fat Restriction group at 90 
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min, the blood glucose level became similar to the Control group (8.46 ±0.36 mmol/L;       
Fig. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  2:  Blood  glucose  levels  at  90  minutes  after  injection  of  D‐glucose  (2mg/g  body  weight)  in 
Control, High‐Fat and Fat Restriction groups (n=10‐11/group). Values represent means ± stand error. 
(* P < 0.05 vs. Control; † P < 0.05 vs. High‐Fat group).  
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3.3. Effect of High-Fat Diet and Dietary Fat Restriction on Vascular 
Function  
 
3.3.1.   Acetylcholine-Dependent Relaxation 
Endothelium-dependent relaxation to acetylcholine was analyzed in the aorta and carotid rings 
in Control, High-Fat and Fat Restriction groups. Vascular relaxation was investigated in 
presence of prostanoids and nitric oxide as shown in Fig. 3. 
 
 
 
 
 
 
 
 
 
 
Fig. 3:   Endothelium‐dependent  relaxation  to acetylcholine  in aorta and  carotid artery  in Control, 
High‐Fat and Fat Restriction groups. Vascular  rings were precontracted with phenylephrine before 
adding  acetylcholine  (0.1  nmol/L‐  30  µmol/L)  in  a  concentration‐dependent  manner.  Data  are 
expressed  as  a  percentage  of  precontraction  with  phenylephrine.  Aorta:  n=8‐13/group;  Carotid 
artery: n=5‐8/group. *P<0.05 for carotid artery vs. aorta. 
 
 In the carotid artery, acetylcholine evoked a biphasic response, which was not seen in the 
aorta. In response to low concentrations of acetylcholine (100 nmol/L), carotid artery rings 
showed a relaxation (maximal relaxation as percentage of concentration to PE at 30 nmol/L: 
Control: -83.42±7.05; High-Fat: -86.33±4.12; Fat Restriction: -74.62±5.52), whereas above 
this concentration a contractile response was observed (final relaxation percentage at 30 
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µmol/l: Control: -47.33±7.86; High-Fat: -41.9±5.65; Fat Restriction: -31.77±9.71). In aortic 
rings, the contractile response was absent (maximal relaxation as percentage of contraction to 
PE: Control: -85.09±3.64; High-Fat: -86.01±3.02; Fat Restriction: -81.33±5.08). 
 
3.3.2. Acetylcholine-Dependent Relaxation in the Absence of Prostanoids 
To examine whether prostanoids are involved in the acetylcholine-dependent response, 
vessels were pretreated with meclofenamate (1 µmol/L), a non-selective COX-inhibitor,    
(Fig. 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  4:  Endothelium‐dependent  relaxation  to  acetylcholine  in  aorta  and  carotid  artery  in  Control, 
High‐Fat  and  Fat  Restriction  groups.  Phenylephrine  precontracted  vessels  were  pretreated  with 
meclofenamate  (1 µmol/L)  for  30 min  followed by  acetylcholine  treatment  (10 µmol/L). Data  are 
expressed as a percentage of precontraction with phenylephrine. Aorta: n= 8/group; Carotid artery: 
n= 4/ group).  
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In the carotid artery, pretreatment with meclofenamate completely abolished the contractile 
response at high concentrations of acetylcholine and the rings dilated in all the three diet 
groups (Fig. 4). The final relaxation percentage in the carotid artery was:                       
Control: -97.22±2.77; High-Fat: -93.75±6.2; Fat Restriction: -86.30±4.8. The final relaxation 
percentage in aorta was: Control: -90±2.21; High-Fat: -97.16±2.71;                       
Fat Restriction: -91.46±2.3 (Fig. 4)  
 
3.3.3. Acetylcholine-Dependent Vasoreactivity in the Absence of Nitric Oxide 
To examine the response to acetylcholine in NO-depleted conditions, L-NAME (300 µmol/L) 
was used. The relaxant response after acetylcholine addition was blocked after pretreatment 
with L-NAME (Fig. 5), and only contractions were observed.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Endothelium‐dependent contractions to acetylcholine in aorta and carotid artery of mice from 
Control, High‐Fat and Fat Restriction groups. Phenylephrine precontracted vessels were pretreated 
with L‐NAME (300 µmol/l) for 30 min followed by acetylcholine (0.1 nmol/L ‐ 30 µmol/L) treatment. 
Data are expressed as a percentage to KCl. Aorta: n=5‐9/group and Carotid artery: n= 5‐8/ group.*P< 
0.05 vs. Control and Fat Restriction, † P< 0.05 vs. Control and Fat Restriction. 
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In the aorta, the contractile response occurred only at high concentration of acetylcholine 
100 nmol/L. The contraction was enhanced by 3.4-fold in the High-Fat group in comparison 
with the Control group in the aortic rings (Control: 14.58±1.78% vs. High-Fat: 51.37±1.78%; 
P< 0.05).  Interestingly in the Fat Restriction group, the contraction was attenuated to a level 
similar to the Control group (Fat Restriction: 13.48±2.32% vs. Control: 14.58±1.78%). The 
carotid artery rings were more sensitive to acetylcholine and showed a contractile response 
starting at  30 nmol/L of acetylcholine. In the carotid artery, the contractile response was 
enhanced in the Control group in comparison to the aorta. Maximal contraction was observed 
in the High-Fat group in carotid artery (Control: 31.64± 5.76% vs. High-Fat: 56.04±3.69; P< 
0.05). The contraction in the Fat Restriction group was attenuated similar to the Control group 
in the carotid artery (Fat Restriction: 35.8±2.96% vs. Control: 31.64±5.76%). 
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4.        Discussion 
4.1. Summary 
In the present study, high dietary fat feeding increased body weight and impaired glucose 
tolerance in young mice, and these effects were restored to a similar level as in control 
animals after dietary fat restriction. Feeding of high dietary fat did not alter endothelium-
dependent relaxation in aortae and carotid arteries in the presence or absence of prostanoids. 
Dietary fat restriction also had no effect on relaxation. However, in the absence of nitric oxide 
(NO), endothelium-dependent contractions were induced in aortae and carotid arteries and 
these were enhanced after high dietary fat intake. Interestingly, these contractions were 
attenuated after dietary fat restriction to similar levels as in control animals. In the carotid 
artery, acetylcholine evoked a biphasic response with an initial relaxation, followed by a 
contractile response in all the treatment groups, whereas in the aorta this contractile response 
was absent and only relaxation occurred. After depletion of prostanoids with meclofenamate, 
the contractions present in carotid artery were absent and only relaxation was obtained. In the 
absence of endogenous NO, acetylcholine-mediated relaxations were abolished and only 
endothelium-derived contractions were observed in both carotid artery and aorta. In the 
carotid artery, acetylcholine mediated strong contractions in all the three groups in 
comparison to the aorta. These data suggest that endothelium-dependent reactivity differs 
between aorta and carotid artery. Moreover, endothelium-dependent contractile responses are 
further enhanced after high-fat diet. Switching of high-fat to low-fat diet attenuates these 
contractions to a similar level observed in control animals. This suggests that long-term 
reduction in dietary fat intake has beneficial effects on metabolism, and also on vascular 
function in children. 
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4.2. Weight Gain and Glucose Tolerance 
In the present study, mice fed with high-fat diet were significantly heavier than the control 
animals fed with standard chow. Additionally, the glucose tolerance was markedly impaired 
after high-fat diet in young animals. Body weight and glucose tolerance improved 
significantly after mice were fed with a fat restriction diet and the values were similar to those 
of the control animals. This suggests that reduction in intake of high-fat diet normalizes body 
weight and glucose tolerance in young animals. 
The suitability of the C57BL/6J mice fed with a high-fat diet as a useful rodent model for 
metabolic changes and vascular research has been shown in different studies.82, 83 The 
metabolic changes in C57BL/6J mice after high-fat are comparable to the metabolic changes 
in humans, which are mainly characterized by  insulin resistance due to obesity.83 In the 
present study, C57BL/6J mice were analyzed at the age of 34 weeks, which is comparable 
with early adolescence in human beings and thus is an useful model for understanding 
metabolic and vascular changes in childhood.84  
Obesity is associated with an excessive intake of a high caloric diet and decrease in physical 
activity.85 To promote overweight, which consists of an increase in fat tissue in visceral 
regions, the typical “western diet” is used.82 The classical western diet is rich in 
carbohydrates, especially oligo- and disaccharides, and lipids, mainly consisting of saturated 
fatty acids.82, 86 These macronutrient pattern leads to metabolic changes, like insulin 
resistance, hyperinsulinemia, dyslipidemia, elevated blood pressure and vascular 
dysfunction.87  
 In a previous dietary fat restriction study, the effects of switching from high-fat to a low-fat 
diet in Sprague-Dawley rats (SD) were investigated.88 Fat restriction was performed by 
feeding 3 week-old male SD rats with a high-fat diet (HFD) for 23 weeks followed by low-fat 
diet (LFD) for 20 weeks.  The body weight of rats exposed to dietary fat restriction reduced in 
comparison to rats fed only a HFD for 43 weeks, however the body weights were higher than 
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control mice fed only a LFD. This data does not corroborate to our findings since in our study 
the body weights in mice after dietary fat restriction were similar to control animals. The 
reasons may be: Firstly, we fed the high-fat diet only for 15 weeks, whereas the duration of 
their high-fat feeding was 23 weeks. Secondly, their rodent model was rat, while we used 
C57BL/6J mice, which may contribute to non-comparable metabolic effects. In these rats 
even though there was no difference between serum insulin, glucose, total cholesterol, 
triglyceride levels between the groups but the liver showed steatosis even after dietary fat 
restriction. The authors suggest that a long-term high-fat diet can induce hepatic steatosis, 
which can be an irreversible effect and cannot be improved even after switching to a LFD. 88  
Excessive calorie intake and subsequent obesity increases not only the risk of developing 
chronic diseases, it also decreases life expectancy.89 Already in 1935 Mc Cay et al.,  published 
the first scientific paper to report that calorie restriction in rats, when carried out after puberty, 
extended median and maximum life span and prevented or attenuated the severity of chronic 
disease.89 Data from different studies using in laboratory rodents showed that, in part, calorie 
restriction increases longevity by preventing or delaying chronic diseases, like diabetes, 
atherosclerosis, cardiomyopathy, autoimmune diseases, and cancer.90-94 The mechanisms 
responsible for calorie restriction-mediated effects on aging include decreased production of 
reactive oxygen species and modulation of the endogenous antioxidant system, which 
decrease oxidative stress and free radical-induced tissue damage.95 Another calorie-
restriction-mediated effect is a decrease of sympathetic nervous system activity,96 which leads 
to a decrease in body temperature and whole-body resting energy expenditure from baseline. 
97, 98 Furthermore, other studies showed a reduction in systemic inflammation by a decrease in 
plasma concentrations of inflammatory cytokines and modest increase in levels of circulating 
cortisol.99-102 Two ongoing studies in rhesus monkeys show similar beneficial effects of 
calorie restrictions such as lower body weight,103 lower core temperature and resting energy 
expenditure,97, 98 reduced T3 (Triiodothyronine, one of the hormones, produced by thyroid) 
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concentration104 and improvement in risk factors for cardiovascular diseases like blood 
pressure, serum lipid profile, serum glucose and insulin concentration and insulin 
sensitivity,105-107 decreased inflammatory markers and increased oxidative stress.108 Similar 
positive effects of calorie-restriction have been seen in humans including low percentage of 
body fat, low systolic and diastolic blood pressures, improved lipid profile, increased insulin 
sensitivity, low plasma concentrations of inflammatory markers, low serum concentration of 
T3 and low levels of circulating growth factors.109-111 In addition, left ventricular diastolic 
function with better viscoelasticity and less stiffness was suggested as another beneficial 
effect of calorie restriction.111 The left ventricular heart function was even comparable to 
those who were 16 years younger.111 It is evident that obesity is associated with impaired 
function of most organ systems and premature mortality.112-114 Weight loss, due to reduced 
energy intake, improves metabolic risk factors for cardiovascular disease and other medical 
abnormalities due to obesity.115 Interestingly, bariatric surgery-induced calorie restriction 
leads to long-term weight loss, improves obesity-related complications and can decrease 
mortality rate in extremely obese human.116, 117 But liposuction, by removing large amount of 
body fats, does not improve insulin sensitivity or other metabolic risk factors for 
cardiovascular disease.118 Thus dietary fat restriction, which is a form of calorie restriction, is 
one of the corner stones to reduce the raising prevalence of overweight and obesity.89 
 
4.3. Effect of High-Fat Diet and Dietary Fat Restriction on Vascular 
Tone 
 
In the present study, endothelium-dependent vascular relaxations to acetylcholine were 
examined in the presence of prostanoids and nitric oxide. Vascular rings were precontracted 
with phenylephrine before adding acetylcholine in a concentration-dependent manner. 
Interestingly, the responses between the carotid artery and the aorta were different. In the 
aorta only relaxation occurred whereas the carotid artery showed a biphasic response, 
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relaxation followed by contraction. In carotid artery, the relaxations occurred at lower 
concentrations of acetylcholine and maximal vascular relaxation was similar in carotid artery 
and aorta, and was unaffected by high-fat diet or dietary fat restriction. At higher 
concentrations of acetylcholine, a contractile response was observed in carotid artery in the 
three diet groups and this effect was absent in aorta. Reasons for this different reactivity 
patterns between the two vascular beds may be: 1. the anatomy of the vascular ring, 
particularly the proportionality of smooth muscle cells; 2. differences in the expression of 
acetylcholine-specific receptors; and 3. differences in the expression or activity of the 
intracellular signaling molecules.  
In the present study, treatment with meclofenamate, a non-selective cyclooxygenase inhibitor, 
abolished these endothelium-dependent contractions in the carotid artery. Thus,  
cyclooxygenase-derived endoperoxides contribute to the endothelium-mediated contractile 
responses and depletion of prostanoids mediated relaxation in the three diet groups. Treatment 
with L-NAME led to a nitric oxide-depleted condition and blocked the relaxation response 
after acetylcholine treatment and only contractions were observed. In this condition, the 
carotid artery was more sensitive to acetylcholine showing a contractile response already at 
lower concentrations of acetylcholine compared to aorta. The contractile response was 
enhanced after high-fat diet. Interestingly, the contraction in the Fat Restriction group was 
attenuated similar to the Control group. In the aortic rings, the contractile response occurred 
only at high concentrations of acetylcholine and was also enhanced after high-fat diet. Dietary 
fat restriction attenuated the contraction to level similar to the Control group. These findings 
suggest that the induction of endothelium-dependent contraction depends on the vascular bed. 
Decreased availability of nitric oxide induces endothelium-dependent contractions, which are 
further amplified after a high-fat diet. Thus a reduction of the bioavailability of nitric oxide 
(NO) is linked to the development of vascular stress 47, 119, which can be related to the 
increased endothelium-dependent contractions. 
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In a recent study using B6D2F1 male mice, carotid artery dilation was impaired in older mice, 
fed standard rodent chow ad libitum in comparison to young mice fed standard rodent chow 
ad libitum.120 With calorie restriction, the impaired dilation in old mice was improved and 
was similar to the younger mice, fed ad libitum or a calorie restriction diet. These findings 
show that short-term calorie restriction restores vascular endothelial function in old mice and 
improves endothelium-dependent dilation.120 In the present study, we did not observe any 
alteration in endothelium-dependent relaxation between the groups. In another study, a 12-
week low-carbohydrate diet has been shown to improve postprandial vascular function in 
human brachial arteries.121 The authors showed a positive effect of dietary carbohydrate 
restriction (CRD) in comparison to low-fat diet (LFD) on flow-mediated dilation.121 After 12 
weeks, peak flow-mediated dilation at 3 hours increased from 5.1% to 6.5% in the CRD group 
and decreased from 7.9% to 5.2% in the LFD group.121 Several other reports indicate that 6 
months of weight reduction and exercise improve macrovascular endothelial function and 
reduce selective markers of endothelial activation and coagulation in obese subjects with 
metabolic syndrome regardless of the degree of glucose tolerance.122, 123 A recent study 
showed that weight reduction with very low-calorie diet improved flow-mediated vasodilation 
in obese individuals and the improvement was related to the reduction in plasma glucose 
concentration.124 1 year of a multidisciplinary weight reduction program caused a reduction in 
body weight by 10% along with a reduction in cytokine and adhesion concentrations and an 
improvement of vascular response to L-arginine in 56 healthy premenopausal obese women 
with a mean body mass index 37.2 kg/m2.125, 126 After 2-week of low calorie diet (800 kcal/d), 
a significant improvement in flow-mediated dilatation was observed in obese hypertensive 
patients.127 In children, an improvement of endothelial function has been observed when both 
diet and exercise were associated.128 Thus, in line with our findings these studies also suggest 
a beneficial role of dietary fat restriction on endothelial function. 
 
 34
4.4. Limitations of the study 
In the present study, following were the limiting factors: 1. The number of animals is in the 
range of 4 to 13 per group, causing a limitation in statistical significance. 2. In the present 
study, animals were fed only for 15 weeks of standard chow after high-fat diet feeding for 15 
weeks. Therefore the possible effects associated with decreased duration of treatment with 
standard chow after high-fat feeding was not studied. 3. Whether similar effects also occur in 
older animals were not examined. 4. Only elastic-type of arteries were examined.  
 
4.5. Conclusion and Clinical Implication 
The present study shows that increased endothelium-mediated contractions occur in elastic 
arteries of obese adolescent mice due to high-fat diet intake. These effects were accompanied 
by weight gain and impaired glucose tolerance. These changes can be improved, and even 
normalized, by restricting the intake of fat or by switching from classical western type diet to 
a normal diet, low in fats. In healthy vessels, acetylcholine causes normally vasodilation, but 
by enhanced fat intake the homeostasis of vascular tone is disturbed and thus the vascular bed 
shows a greater tendency to vasoconstriction. Therapeutic strategies that reduce vascular 
oxidative stress, increase NO bioavailability and reverse impairment in endothelium-
dependent reactivity may have important clinical implication for the prevention of 
cardiovascular disease in humans.120 
The main topic of this study was to obtain more knowledge of vascular changes induced by 
fat restriction compared to high-fat feeding. Whether, the effects mediated by short-term 
dietary fat treatment were irreversible even after reduction in dietary fat content was not clear. 
In this study, we show that reduction in dietary fat content rescued endothelium-dependent 
contractions. It is important to realize that metabolic and vascular changes initiate already in 
early life. But even more important and more difficult is to counteract these early changes. 
And in this study, we show that significant reduction in dietary fat content for a long period 
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normalized effects contributed by high-fat diet. Since the present study deals with young 
animals, we are not sure whether similar results will be observed once adulthood is reached. 
Moreover, aging is an additional cardiovascular risk factor.  
In the last few decades, our lifestyle has changed dramatically. In earlier years, human beings 
had to work more physically to earn money for their existence.  The daily routine was more 
dependent on body-work. Today, with the modernity, everything has become more easy, 
surely more specialized and professional, but often associated with less body-activity, that 
means less body-work. With the growing culture of computer, internet and other virtual 
activities, including games and chats, our children and adolescents are more attracted in 
spending their free-time in front of a computer or playing other indoor games, without much 
physical activity, than playing outdoor activities. This modernization and acceleration of our 
daily life and life content is an important co-factor of the increasing obesity incidence and 
childhood obesity, in particular.  
Another important reason is the socio-economic aspect. In spite of more knowledge and  
growth, the socio-economic problems has not become smaller, in contrary, the gap between 
the different social leagues have become even greater. That’s why today, even in a normal 
under or middleclass 4-or 5-head family, a one person’s income is mostly not enough and 
both parent’s need to work to run the family’s needs. This means, that children have to create 
their day often alone, especially they have to eat alone, which does not lead to a behavioral 
nutrition. Tim Lobstein describes in his work in 2008 a so-called “obesogenic economy”, that 
is characterized by two main points. The first point is, that actually food companies influence 
what the consumer wants. Data from 2003 in UK show that food companies spend a high 
amount of money on marketing their products, mostly high in fats, sugar and or salt, and low 
in fresh fruit or vegetables. Only a small budget was spent by government for the promotion 
of healthy diets.129 The second point is that, food market is considerably supported by 
government incentives to produce high levels of meat, milk butter and cheese, sugar and oil 
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and only a small budget is used for the production of fruit and vegetables and fish.129, 130 This 
“obesogenic economy” is surely responsible to the growing prevalence of overweight and 
obesity with all its consequences.  
In this study, we investigated the importance of reduction in fat intake to avoid obesity and to 
reach and keep an “optimal health”. The “optimal health” for each individual person is 
difficult to define, but  to sum it up it can be declared as  the state in which there is the highest 
possible attainment of mental, physical, and social well-being and the lowest risk of 
developing diseases in future.89 Suggested clinical criteria to provide optimal health are lower 
than previous cut-off values; for systolic and diastolic blood pressure (< 115/75 mmHg vs. a 
previous threshold of 140/80 mmHg),131, 132 concentration of plasma low-density lipoprotein 
cholesterol (1.3-1.8 mmol/L vs. a previous threshold of < 2.6 mmol/L),133 and lower 
concentrations of fasting plasma glucose (4.2 mmol/L vs. a previous threshold of < 5.6 
mmol/L)134, 135. The precise amount of the optimal calorie intake or body mass index for each 
individual associated with “optimal health” is not known till now, but the WHO and other 
groups have proposed that a BMI between 18.5 to 24.9 is optimal.89 
It is not yet clear whether these suggested clinical criteria are realizable and do not lead to a 
“medical over-treating” of our society. But fact is, we have to take care of our fat intake and 
body weight, beginning already in early age to prevent the onset of overweight and obesity 
with all its clinical and economical consequences. 
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